Oncology Studies

  • Home
  • Oncology Studies
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE(R)), Stage 3-Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Conditions: Adrenocortical Carcinoma (ACC); Recurrent Adrenocortical Carcinoma (ACC); Recurrent Abdominal Adrenocortical Carcinoma (ACC); Carcinoma, Adrenocortical; Carcinoma, Adrenal Cortical
Interventions: Radiation: Preoperative external beam radiation therapy (EBRT); Procedure: Surgical resection
Sponsors: National Cancer Institute (NCI)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 14, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Cervical Sample Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial
Conditions: Cervical Carcinoma; Human Papillomavirus Infection

Interventions: Procedure: Biospecimen Collection; Procedure: Cervical Biopsy; Procedure: Colposcopy; Procedure: Endocervical Curettage; Procedure: Excision; Procedure: HPV Self-Collection; Procedure: Human Papillomavirus Test; Other: Questionnaire Administration; Other: Survey Administration

Sponsors: National Cancer Institute (NCI)

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 14, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Effort During Resistance Training in Type 2 Diabetes

Conditions: Type2 Diabetes Mellitus
Interventions: Behavioral: High-effort resistance exercise training; Behavioral: Low-effort resistance exercise training
Sponsors: University of New Mexico
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type II
Interventions: Drug: HM-002-1005
Sponsors: Hua Medicine Limited
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Study of WAL0921 in Patients With Glomerular Kidney Diseases

Conditions: Diabetic Nephropathies; Primary Focal Segmental Glomerulosclerosis; Minimal Change Disease; Primary Immunoglobulin A Nephropathy; Primary Membranous Nephropathy
Interventions: Drug: WAL0921; Drug: Placebo
Sponsors: Walden Biosciences
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool

Conditions: PreDiabetes; Lifestyle, Healthy; Activation, Patient
Interventions: Behavioral: Diabetes Prevention Patient Activation Clinical Decision Support Tool
Sponsors: Johns Hopkins University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Technology Delivered Diabetes-Modified Behavioral Activation Treatment

Conditions: Diabetes Mellitus, Type 2
Interventions: Behavioral: TECH DM-BAT; Behavioral: TECH DMBAT Active Comparator; Behavioral: TECH DMBAT Other
Sponsors: State University of New York at Buffalo
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents

Conditions: Type 1 Diabetes
Interventions: Other: TeKnO T1D: Parents
Sponsors: Children’s Hospital of Philadelphia
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Conditions: Locally Advanced Pancreatic Cancer
Interventions: Drug: Gemcitabine; Drug: nab-paclitaxel; Device: RenovoCath
Sponsors: RenovoRx
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)

Conditions: Diabetes Mellitus; Type 2 Diabetes Mellitus; Adult-Onset Diabetes Mellitus; Non-Insulin-Dependent Diabetes Mellitus; Noninsulin Dependent Diabetes Mellitus, Type II
Interventions: Behavioral: High Frequency Financial Incentive; Behavioral: Moderate Frequency Financial Incentive; Behavioral: Low Frequency Financial Incentive
Sponsors: State University of New York at Buffalo; Medical University of South Carolina
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine